Genovese Burford & Brothers Wealth & Retirement Plan Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | $385K | Sell |
10,471
-275
| -3% | -$10.1K | 0.1% | 75 |
|
|
2020
Q3 | $374K | Buy |
10,746
+292
| +3% | +$10.2K | 0.11% | 60 |
|
|
2020
Q2 | $324K | Sell |
10,454
-347
| -3% | -$10.8K | 0.09% | 58 |
|
|
2020
Q1 | $335K | Buy |
10,801
+180
| +2% | +$5.58K | 0.09% | 59 |
|
|
2019
Q4 | $395K | Sell |
10,621
-2,488
| -19% | -$92.5K | 0.09% | 72 |
|
|
2019
Q3 | $447K | Buy |
13,109
+172
| +1% | +$5.87K | 0.11% | 62 |
|
|
2019
Q2 | $532K | Buy |
12,937
+1,251
| +11% | +$51.4K | 0.14% | 56 |
|
|
2019
Q1 | $471K | Sell |
11,686
-4,060
| -26% | -$164K | 0.13% | 56 |
|
|
2018
Q4 | $652K | Buy |
15,746
+4,223
| +37% | +$175K | 0.21% | 42 |
|
|
2018
Q3 | $482K | Buy |
11,523
+1,209
| +12% | +$50.6K | 0.16% | 53 |
|
|
2018
Q2 | $355K | Sell |
10,314
-419
| -4% | -$14.4K | 0.13% | 50 |
|
|
2018
Q1 | $361K | Buy |
+10,733
| New | +$361K | 0.13% | 49 |
|
|
2017
Q4 | – | Sell |
-4,111
| Closed | -$139K | – | 393 |
|
|
2017
Q3 | $139K | Buy |
4,111
+151
| +4% | +$5.11K | 0.06% | 73 |
|
|
2017
Q2 | $126K | Sell |
3,960
-290
| -7% | -$9.23K | 0.05% | 84 |
|
|
2017
Q1 | $138K | Sell |
4,250
-6,130
| -59% | -$199K | 0.06% | 83 |
|
|
2016
Q4 | $320K | Buy |
10,380
+4,877
| +89% | +$150K | 0.09% | 47 |
|
|
2016
Q3 | $176K | Sell |
5,503
-500
| -8% | -$16K | 0.07% | 62 |
|
|
2016
Q2 | $200K | Buy |
6,003
+2,293
| +62% | +$76.4K | 0.08% | 61 |
|
|
2016
Q1 | $104K | Sell |
3,710
-954
| -20% | -$26.7K | 0.05% | 89 |
|
|
2015
Q4 | $143K | Buy |
+4,664
| New | +$143K | 0.07% | 67 |
|